ng-nitroarginine methyl ester has been researched along with Demyelinating Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Karami, M; Kouhsar, SS; Nadoushan, MR; Roghani, M; Tafreshi, AP | 1 |
Ma, L; Nagano, S; Soliven, B; Takeda, M | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and Demyelinating Diseases
Article | Year |
---|---|
Microinjection of l-arginine into corpus callosum cause reduction in myelin concentration and neuroinflammation.
Topics: Animals; Arginine; Conditioning, Operant; Corpus Callosum; Demyelinating Diseases; Dose-Response Relationship, Drug; Drug Interactions; Encephalitis; Enzyme Inhibitors; Exploratory Behavior; Female; Maze Learning; Memory Disorders; Microinjections; Myelin Sheath; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar | 2011 |
Cytokine-induced cell death in immortalized Schwann cells: roles of nitric oxide and cyclic AMP.
Topics: Animals; Apoptosis; Cell Differentiation; Cell Line, Transformed; Cell Survival; Ceramides; Colforsin; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Demyelinating Diseases; Enzyme Inhibitors; Guillain-Barre Syndrome; Interferon-gamma; Mitogen-Activated Protein Kinases; Neuroimmunomodulation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phosphatidylinositol 3-Kinases; Rats; Schwann Cells; Signal Transduction; Tumor Necrosis Factor-alpha | 2001 |